Oppenheimer Asset Management Inc. Has $7.46 Million Position in Humana Inc. (NYSE:HUM)

Oppenheimer Asset Management Inc. boosted its position in shares of Humana Inc. (NYSE:HUM) by 18.1% during the 2nd quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 19,957 shares of the insurance provider’s stock after buying an additional 3,057 shares during the quarter. Oppenheimer Asset Management Inc.’s holdings in Humana were worth $7,457,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Mendota Financial Group LLC raised its stake in shares of Humana by 9.2% during the second quarter. Mendota Financial Group LLC now owns 319 shares of the insurance provider’s stock worth $119,000 after buying an additional 27 shares during the last quarter. Aurora Investment Counsel raised its position in shares of Humana by 1.3% during the 4th quarter. Aurora Investment Counsel now owns 2,273 shares of the insurance provider’s stock valued at $1,155,000 after acquiring an additional 29 shares during the last quarter. Capital Advisors Ltd. LLC lifted its stake in shares of Humana by 17.0% in the 2nd quarter. Capital Advisors Ltd. LLC now owns 213 shares of the insurance provider’s stock valued at $80,000 after purchasing an additional 31 shares during the period. EP Wealth Advisors LLC boosted its position in shares of Humana by 1.6% in the 4th quarter. EP Wealth Advisors LLC now owns 2,294 shares of the insurance provider’s stock worth $1,050,000 after purchasing an additional 37 shares during the last quarter. Finally, CarsonAllaria Wealth Management Ltd. grew its stake in shares of Humana by 111.4% during the second quarter. CarsonAllaria Wealth Management Ltd. now owns 74 shares of the insurance provider’s stock worth $28,000 after purchasing an additional 39 shares during the period. 92.38% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of brokerages have issued reports on HUM. Truist Financial raised their target price on Humana from $355.00 to $400.00 and gave the stock a “hold” rating in a report on Monday, July 15th. JPMorgan Chase & Co. lifted their price objective on shares of Humana from $332.00 to $396.00 and gave the stock a “neutral” rating in a research note on Wednesday, August 21st. Oppenheimer upped their target price on shares of Humana from $370.00 to $400.00 and gave the company an “outperform” rating in a research note on Thursday, August 1st. Baird R W raised shares of Humana to a “hold” rating in a research report on Thursday, May 30th. Finally, Robert W. Baird initiated coverage on shares of Humana in a research report on Thursday, May 30th. They issued a “neutral” rating and a $374.00 price objective for the company. Thirteen investment analysts have rated the stock with a hold rating and nine have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of “Hold” and an average price target of $398.70.

Humana Trading Down 0.9 %

Shares of NYSE:HUM opened at $321.56 on Monday. Humana Inc. has a 52-week low of $298.61 and a 52-week high of $530.54. The company has a debt-to-equity ratio of 0.70, a quick ratio of 1.66 and a current ratio of 1.66. The company has a market capitalization of $38.72 billion, a P/E ratio of 20.02, a price-to-earnings-growth ratio of 2.56 and a beta of 0.50. The company has a 50-day simple moving average of $364.11 and a 200 day simple moving average of $346.85.

Humana (NYSE:HUM) last released its quarterly earnings data on Wednesday, July 31st. The insurance provider reported $6.96 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $5.89 by $1.07. Humana had a return on equity of 16.12% and a net margin of 1.53%. The company had revenue of $29.54 billion during the quarter, compared to analysts’ expectations of $28.52 billion. During the same period last year, the firm posted $8.94 earnings per share. The business’s revenue was up 10.4% on a year-over-year basis. Sell-side analysts forecast that Humana Inc. will post 16 earnings per share for the current year.

Humana Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Friday, October 25th. Stockholders of record on Monday, September 30th will be paid a dividend of $0.885 per share. This represents a $3.54 dividend on an annualized basis and a dividend yield of 1.10%. The ex-dividend date of this dividend is Monday, September 30th. Humana’s dividend payout ratio is presently 22.04%.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.